<SEC-DOCUMENT>0001737287-22-000028-index.html : 20220426
<SEC-HEADER>0001737287-22-000028.hdr.sgml : 20220426
<ACCEPTANCE-DATETIME>20220426163540
ACCESSION NUMBER:		0001737287-22-000028
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20220426
DATE AS OF CHANGE:		20220426

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Allogene Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001737287
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				823562771
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38693
		FILM NUMBER:		22854870

	BUSINESS ADDRESS:	
		STREET 1:		210 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 457-2700

	MAIL ADDRESS:	
		STREET 1:		210 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>allo-20220426xdefa14axnoti.htm
<DESCRIPTION>DEFA14A
<TEXT>
Document 1 - file: allo-20220426xdefa14axnoti.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>noticecard1.jpg
<TEXT>
Document 2 - file: noticecard1.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>noticecard2.jpg
<TEXT>
Document 3 - file: noticecard2.jpg

</DOCUMENT>
</SEC-DOCUMENT>